Lorvotuzumab mertansine: antibody-drug-conjugate for CD56⁺ multiple myeloma

Title
Lorvotuzumab mertansine: antibody-drug-conjugate for CD56⁺ multiple myeloma
Authors
Keywords
-
Journal
Frontiers in Bioscience-Landmark
Volume 19, Issue 1, Pages 163
Publisher
Frontiers in Bioscience
Online
2014-01-05
DOI
10.2741/4202

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started